BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calvaruso V, Cacciola I, Licata A, Madonia S, Benigno R, Petta S, Bronte F, Conte E, Malizia G, Bertino G, Distefano M, Montineri A, Digiacomo A, Alaimo G, Cacopardo B, Davì A, Guarneri L, Scalisi I, Colletti P, Cartabellotta F, Portelli V, Prestileo T, Averna A, Iacobello C, Mondello L, Scifo G, Russello M, Squadrito G, Raimondo G, Cammà C, Craxì A, Di Marco V; RESIST-HCV (Rete Sicilia Selezione Terapia–HCV). Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience. Am J Gastroenterol 2019;114:1275-82. [PMID: 31135449 DOI: 10.14309/ajg.0000000000000266] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan Y, Xing X, Lu Q, Wang X, Luo X, Yang L. Two-Dimensional Shear Wave Elastography for Sparing Endoscopy Screening in Patients with HBV-Related Compensated Advanced Chronic Liver Disease. Expert Rev Gastroenterol Hepatol 2021. [PMID: 34939906 DOI: 10.1080/17474124.2022.2020644] [Reference Citation Analysis]
2 Cerrito L, Ainora ME, Nicoletti A, Garcovich M, Riccardi L, Pompili M, Gasbarrini A, Zocco MA. Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals. World J Hepatol 2021; 13(11): 1663-1676 [PMID: 34904036 DOI: 10.4254/wjh.v13.i11.1663] [Reference Citation Analysis]
3 Hu Y, Wen Z. Validation and comparison of non-invasive prediction models based on liver stiffness measurement to identify patients who could avoid gastroscopy. Sci Rep 2021;11:150. [PMID: 33420233 DOI: 10.1038/s41598-020-80136-0] [Reference Citation Analysis]
4 Xu X, Jin Y, Lin Y, Hu D, Zhou Y, Li D, Wang H, Jin C. Multimodal Ultrasound Model Based on the Left Gastric Vein in B-Viral Cirrhosis: Noninvasive Prediction of Esophageal Varices. Clin Transl Gastroenterol 2020;11:e00262. [PMID: 33259161 DOI: 10.14309/ctg.0000000000000262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kulkarni AV, Anand AC. Non-invasive tests, Portal hypertension, and Beta-blockers: A step towards a greener environment! Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.03.011] [Reference Citation Analysis]
6 Kim NJ, Su F, Biggins SW. CON: Noninvasive Modalities Are Preferred to Screen for the Diagnosis of Esophageal and Gastric Varices When the Diagnosis of Cirrhosis Is Made. Clin Liver Dis (Hoboken) 2020;16:48-52. [PMID: 32922749 DOI: 10.1002/cld.952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Duan Z, Li L, Li J, Zhou S. Validation of the Combined Model Based on Platelet Count and Albumin to Rule out High-Risk Varices in Liver Cirrhosis. Biomed Res Int 2020;2020:5783748. [PMID: 32766309 DOI: 10.1155/2020/5783748] [Reference Citation Analysis]
8 Zhou H, Hu H, Tian M, Chu J, Tian C, Yang Y, Lin S. Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices. Gastroenterol Res Pract 2020;2020:4217512. [PMID: 33376483 DOI: 10.1155/2020/4217512] [Reference Citation Analysis]
9 Kotwal V, Mbachi C, Wang Y, Attar B, Randhawa T, Flores E, Robles J, Rosenstengle C, Demetria M, Adeyemi O, Huhn G, Murali AR. A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease. Dig Dis Sci 2021;66:2084-91. [PMID: 32648078 DOI: 10.1007/s10620-020-06456-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Li X, Kang N, Qi X, Huang Y. Artificial intelligence in the diagnosis of cirrhosis and portal hypertension. J Med Ultrason (2001) 2021. [PMID: 34787742 DOI: 10.1007/s10396-021-01153-8] [Reference Citation Analysis]
11 Szakács Z, Erőss B, Soós A, Mátrai P, Szabó I, Pétervári E, Bajor J, Farkas N, Hegyi P, Illés A, Solymár M, Balaskó M, Sarlós P, Szűcs Á, Czimmer J, Vincze Á, Pár G. Baveno Criteria Safely Identify Patients With Compensated Advanced Chronic Liver Disease Who Can Avoid Variceal Screening Endoscopy: A Diagnostic Test Accuracy Meta-Analysis. Front Physiol 2019;10:1028. [PMID: 31481896 DOI: 10.3389/fphys.2019.01028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
12 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., Clinical Practice Guideline Panel., Chair:., EASL Governing Board representative:., Panel members:. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol 2021;75:659-89. [PMID: 34166721 DOI: 10.1016/j.jhep.2021.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 16.0] [Reference Citation Analysis]
13 Argalia G, Tarantino G, Ventura C, Campioni D, Tagliati C, Guardati P, Kostandini A, Marzioni M, Giuseppetti GM, Giovagnoni A. Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals. Radiol Med 2021;126:894-9. [PMID: 33492651 DOI: 10.1007/s11547-020-01326-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Licata A, Minissale MG, Giannitrapani L, Montalto FA, Lombardo C, Mirarchi L, Amodeo S, Soresi M, Montalto G. Comorbidities impact and de-prescribing in elderly with HCV-related liver disease: analysis of a prospective cohort. Intern Emerg Med 2021. [PMID: 33909256 DOI: 10.1007/s11739-021-02741-9] [Reference Citation Analysis]
15 Bertino G, Ragusa R, Corsaro LS, Frazzetto E, Messina V, Inguscio L, Lai C, Maglia M, Nunnari A, Caponnetto P. Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2). Health Psychol Res 2020;8:9450. [PMID: 33553794 DOI: 10.4081/hpr.2020.9450] [Reference Citation Analysis]
16 Sharma S, Agarwal S, Gunjan D, Kaushal K, Anand A, Saraya A. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort. Am J Gastroenterol 2020;115:1650-6. [PMID: 32516202 DOI: 10.14309/ajg.0000000000000722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Agarwal S, Sharma S, Jindal A, Singh S, Jagdish R, Gunjan D, Sarin SK, Saraya A. Application of Noninvasive Tools to Decide the Need for Beta-Blockers for Variceal Bleeding Prophylaxis in Compensated Advanced Liver Disease: A Decision Curve Analysis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.09.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Agarwal A, Pathak P, Gupta S, Kumar R, Shalimar. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment. Indian J Gastroenterol 2021. [PMID: 33991311 DOI: 10.1007/s12664-020-01141-9] [Reference Citation Analysis]
19 Cacciola I, Russo G, Filomia R, Pitrone C, Caccamo G, Giandalia A, Alibrandi A, Stella Franzè M, Porcari S, Maimone S, Saitta C, Squadrito G, Raimondo G. Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis. Liver Int 2021;41:2059-67. [PMID: 33894103 DOI: 10.1111/liv.14905] [Reference Citation Analysis]
20 Miyamoto Y, Enomoto H, Nishikawa H, Nishimura T, Iwata Y, Nishiguchi S, Iijima H. Association of the Modified ALBI Grade With Endoscopic Findings of Gastroesophageal Varices. In Vivo 2021;35:1163-8. [PMID: 33622916 DOI: 10.21873/invivo.12364] [Reference Citation Analysis]
21 Wong YJ, Kew GS, Tan PS, Chen Z, Putera M, Yip WA, Ang TL, Fock KM, Lee GH, Hsiang J, Huang DQ, Kwek A, Muthiah MD, Kumar R, Tan M, Tan J, Thurairajah PH, Teo EK, Tai BC, Lim SG. Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation study. Clin Res Hepatol Gastroenterol 2021;45:101598. [PMID: 33780835 DOI: 10.1016/j.clinre.2020.101598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]